NCT00555022View on ClinicalTrials.gov

Effect of GSK1160724 In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 12, 2007

Primary Completion Date

April 7, 2008

Study Completion Date

April 7, 2008

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

GSK1160724

GSK1160724 will be available with dosing strengths of 10, 50 and 125 micrograms/blister for inhalation using the DISKUS inhaler.

DRUG

Tiotropium bromide

Tiotropium bromide capsules will be supplied with a dose of 18 micrograms administered via a HandiHaler device.

DRUG

Placebo

Subjects will receive placebo.

Trial Locations (1)

HA1 3UJ

GSK Investigational Site, Harrow

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY